CLINICAL TRIAL IN INDIA-AN OVERVIEW

Global Pharmaceutical companies based in developed countries are increasingly turning to developing countries and emerging economies around the world for conducting clinical trials. Reduced costs combined with easy availability of patients with varied diseases makes developing countries favourite destinations for clinical research outsourcing.

The whole 9 pages article is available for download at Downloads section of FarmavitaR.com

New generation of software for more efficient clinical trials and multicentre projects

Beside the software, IT provider will usually provide tailor made adjustment of software and IT support during project. Application will be a user-friendly, scalable and secure. It will run form any PC configuration and any standard operating system. Project data will be accessible from any computer with Internet connection and much, much more …..

Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets

Innovative Clinical Trial Design and Management is a report published by Business Insights that explores the major types of adaptive design and their role in dose-finding. The report investigates seamless Phase 2/3 trials and adaptive trials in pharmacogenomics, assesses the logistical implications of adaptive trial implementations and reviews the current regulatory standpoints of the FDA and EMEA.

OUTSOURCING CLINICAL TRIALS (OCT)

OUTSOURCING CLINICAL TRIALS (OCT) is a contract research organization (CRO) with head office in St. Petersburg, Russia and provides services to Pharmaceutical companies interested in conducting clinical trials.

Clinical Outsourcing

The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends

Emerging Role of Postmarketing Clinical Research is a report published by Business Insights that uses detailed case studies and market scenarios to examine the latest issues surrounding phase IV trial applications. The potential to leverage competitive advantage with postmarketing research is assessed by measuring the implications for formulary access, product marketing, indication expansion and reimbursement coverage.

Emerging Clinical Trial Locations: Market dynamics and the changing healthcare and regulatory environment

This report provides a comprehensive examination of the clinical trial landscape in emerging countries, with specific focus on China, India, Central and Eastern Europe and Latin America. It identifies the major drivers and barriers to conducting clinical trials in emerging regions and profiles key issues for consideration when selecting a trial site.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report!